Remote Patient Monitoring Services Market by Component (Devices, Software & Analytics, Services), by Application (Cardiovascular Disease Monitoring, Diabetes Management, Respiratory Disease Monitoring, Weight Management and sleep disorder monitoring), by End User (Hospitals & Providers, Homecare Settings, Payers), by Connectivity (Cellular-Enabled, Bluetooth/Wi-Fi-Enabled, Satellite and Zigbee connectivity), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035
St. Catharines, Ontario, 18 Nov 2026 — Vectomat Insights has published a new report titled ‘Remote Patient Monitoring Services Market by Component, Application, End User, Connectivity, and Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035.’ The Global Remote Patient Monitoring Services market was valued at USD 12,486.2 Mn in 2025 and is projected to reach USD 49,945.5 Mn by 2035, growing at a CAGR of 14.87% during the forecast period 2026–2035, according to Vectomat Insights.
Devices still take the largest slice at 44.0% of 2025 revenue, but managed clinical services are the story to watch: they're compounding at 20.86% a year as health systems such as Providence and Corewell Health hand day-to-day monitoring to outsourced care teams, while North America holds 47.0% of global spend.
The Global Remote Patient Monitoring Services market was valued at USD 12,486.2 Mn in 2025 and will reach USD 49,945.5 Mn by 2035, a 14.87% CAGR, according to Vectomat Insights. North America leads with 47.0% of revenue, devices hold the largest component share at 44.0%, and outsourced clinical monitoring services are the fastest-growing component at 20.86% a year.
Key Insights Snapshot
| Metric | Value |
|---|---|
| Report Title | Global Remote Patient Monitoring Services Market Size, Share, Growth & Forecast By Component, Application, End User, and Connectivity, 2026–2035 |
| Base Year Market Size | USD 12,486.2 Mn (2025) |
| Forecast Market Size | USD 49,945.5 Mn (2035) |
| CAGR | 14.87% |
| Forecast Period | 2026–2035 |
| Dominant Region | North America (47.0%) |
| Fastest-Growing Region | Asia Pacific |
| Dominant Segment | Devices (44.0%) |
| Dominant Application | Cardiovascular Disease Monitoring |
| Report Format | |
| Publisher | Vectomat Insights |
What Healthcare Services Leaders Need to Know About the Remote Patient Monitoring Services Market
Health System CEOs: RPM has moved from pilot to service line: Medicare paid USD 536 Mn for it in 2024, up from USD 15 Mn in 2019. Systems that still run home monitoring as a side project will lose chronic-care patients to partners like Cadence, which now runs programs for Providence and Corewell Health.
Chief Medical Information Officers: The 2026 Medicare codes pay for 2–15 days of data in a 30-day window, so programs no longer lose revenue on patients who miss the old 16-day threshold. Rework your enrollment rules and EHR alert logic this quarter, or you'll leave billable monitoring on the table.
Payer and Managed Care Executives: Providence reports its Cadence-run program cut total cost of care by USD 1,302 per Medicare patient per year. Payers hold 18.2% of 2025 spend; plans that don't contract directly for monitoring will pay for the avoidable admissions instead.
Compliance and Revenue Cycle Directors: HHS-OIG found 43% of 2022 Medicare RPM patients didn't receive all three service components. Audit exposure is real, and a weak documentation trail now carries more financial risk than a slow enrollment ramp.
Healthcare Investors: Services grow at 20.86% a year versus 14.16% for devices, and three platform deals closed between March 2025 and June 2026. Valuations are tilting toward companies that bundle clinical staff with data infrastructure, as Cadence's USD 100 Mn Series C shows.

What Is the Remote Patient Monitoring Services Market?
Remote Patient Monitoring Services Market refers to the paid programs that collect blood pressure, glucose, heart-rhythm, oxygen and weight readings from patients at home and route them to a clinical team that acts on them. Why now? Medicare enrollment in RPM jumped from about 55,000 people in 2019 to nearly 1 million in 2024, and payments hit USD 536 Mn that year, according to HHS-OIG. Health systems can't staff that volume alone, so they're buying the whole package: device, platform and nurse-led monitoring. That's why Vectomat Insights sizes the market at USD 12,486.2 Mn in 2025 and USD 49,945.5 Mn by 2035.
How Is the Remote Patient Monitoring Services Market Segmented?
Devices hold 44.0% of 2025 revenue because every program starts with hardware in the patient's home, whether that's a cellular cuff or Abbott's CardioMEMS sensor. But services are where the money is moving. Outsourced clinical monitoring grows at 20.86% a year and will be the biggest component by 2035, worth USD 21,581.6 Mn. By application, cardiovascular monitoring leads at 31.7%, while diabetes management races ahead at 20.04% annually. Hospitals & Providers are the top buyers at 45.8%, and they're also adding spend faster than anyone else, at 19.6% a year.
This report segments the Remote Patient Monitoring Services market as follows:
- By Component: Devices, Software & Analytics, Services
- By Application: Cardiovascular Disease Monitoring, Diabetes Management, Respiratory Disease Monitoring, Weight Management and sleep disorder monitoring
- By End User: Hospitals & Providers, Homecare Settings, Payers
- By Connectivity: Cellular-Enabled, Bluetooth/Wi-Fi-Enabled, Satellite and Zigbee connectivity
- By Region: North America, Europe, Asia Pacific, Latin America, The Middle East, Africa
Browse the full Remote Patient Monitoring Services Market report →

Which Region Leads the Remote Patient Monitoring Services Market?
North America owns this market. It took 47.0% of 2025 revenue, or USD 5,868.5 Mn, and the U.S. accounted for USD 4,988.2 Mn of that, thanks to Medicare codes that pay monthly for each monitored patient. Europe is second at 22.0%, led by Germany at USD 714.2 Mn and NHS England's virtual wards. Asia Pacific holds 20.0% and is growing fastest: South Korea's market expands at 17.1% a year after its December 2025 telemedicine law, and Japan's at 15.2%. Latin America takes 6.0%, The Middle East 3.0% and Africa 2.0%.

Why Is the Remote Patient Monitoring Services Market Growing?
Chronic Disease Burden in Ageing Populations — About 1.3 billion adults live with hypertension, per WHO, and more than 60% of Medicare enrollees have it. That's the core demand pool for home monitoring.
Expanding Reimbursement for RPM — Medicare RPM payments rose 31% in a year to USD 536 Mn in 2024, and 2026 codes now pay for just 2–15 days of data.
Outsourced Clinical Monitoring Services — Health systems are handing monitoring to outsourced teams: Providence says only 0.6% of encounters handled by Cadence reach its own clinicians.
Longer-Wear and Connected Sensors — Dexcom's 15-day G7 and Abbott's Wi-Fi and cellular CardioMEMS HERO reader cut the effort patients need to stay on a program.
The promise was this continuous stream of objective, reliable data would replace the unreliable, intermittent information we had been forced to make decisions from.
What's Limiting the Remote Patient Monitoring Services Market?
Billing Oversight and Compliance Risk — HHS-OIG found 43% of 2022 Medicare RPM patients missed at least one service component, and enforcement is rising.
Patient Adherence and Data Gaps — Patients who stop sending readings stop generating revenue; device setup and digital literacy still lose enrollees in the first months.
Clinical Staffing and Alert Burden — Every reading needs a reviewer, and in-house nursing teams can't absorb thousands of daily alerts.
Even with tighter billing scrutiny, the market is on course to grow from USD 12,486.2 Mn in 2025 to USD 49,945.5 Mn by 2035.
What Industry Leaders Are Saying About the Remote Patient Monitoring Services Market
FreeStyle Libre has become the most successful medtech product in history.
International markets are a priority for Dexcom's continuous glucose monitoring growth in 2026.
Additional oversight of remote patient monitoring in Medicare is needed to ensure it is used and billed appropriately.
We built Cadence to solve the clinical labor constraint at the heart of the chronic disease crisis.
Report Segmentation & Scope
| Vectomat Insights | Market & Reports — Report Segmentation & Scope | |
|---|---|
| Scope Included in the Study | |
| By Component |
|
| By Application |
|
| By End User |
|
| By Connectivity |
|
| Regional Analysis | |
| North America | The U.S., Canada, Mexico |
| Europe | Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe |
| Asia Pacific | China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific |
| Latin America | Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America |
| The Middle East | GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East |
| Africa | South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa |
| Note: The scope can be further tailored as per your specific requirement. Contact sales@vectomatinsights.com | |
Who Are the Leading Companies in the Remote Patient Monitoring Services Market?
Key players operating in the Global Remote Patient Monitoring Services market include Koninklijke Philips (Netherlands), Medtronic (Ireland), Abbott Laboratories (U.S.), Omron Healthcare (Japan), Dexcom (U.S.), iRhythm Technologies (U.S.), Masimo (U.S.), Vivalink (U.S.), Smart Meter (U.S.), Teladoc Health (U.S.), Biofourmis (U.S.), Cadence (U.S.), Health Recovery Solutions (U.S.), CoachCare (U.S.), ChartSpan (U.S.), among others. The field splits into device majors that own the sensors and service companies that own the patient relationship. That second group is where the deal flow is: CoachCare, Health Recovery Solutions and ChartSpan all bought platforms in 16 months. Device makers aren't standing still either, as Abbott's February 2026 HERO reader approval shows.
What's New in the Remote Patient Monitoring Services Market?
March 2025 — CoachCare: Acquired VitalTech, a Dallas-based enterprise virtual care software company, adding platform capacity to its RPM and chronic care management services.
November 2025 — Centers for Medicare & Medicaid Services: Finalized CY2026 Physician Fee Schedule codes that pay for 2–15 days of remote monitoring data per 30-day period and a shorter management tier, effective 1 January 2026.
February 2026 — Abbott Laboratories: Received FDA approval for the next-generation CardioMEMS HERO pulmonary artery pressure reader with built-in Wi-Fi and cellular connectivity for remote heart failure monitoring.
March 2026 — Health Recovery Solutions: Acquired Rimidi, a diabetes and cardiometabolic care management platform, to expand its remote care programs.
June 2026 — ChartSpan: Acquired Validic, a connected-device and personal health data integration platform, to strengthen its remote patient monitoring capabilities.
June 2026 — Cadence: Raised a USD 100 Mn Series C led by Spark Capital to expand its remote care services, AI agents and value-based care models across health systems.
Frequently Asked Questions
How big is the remote patient monitoring services market?
The global remote patient monitoring services market was worth USD 12,486.2 Mn in 2025 and is projected to reach USD 49,945.5 Mn by 2035, growing at a 14.87% CAGR over 2026–2035. Growth comes from rising Medicare enrollment, new 2026 billing codes for short monitoring periods, and health systems outsourcing day-to-day monitoring to clinical service teams, according to Vectomat Insights.
Which region leads the remote patient monitoring services market?
North America leads with 47.0% of 2025 revenue, or USD 5,868.5 Mn, because Medicare pays monthly fees for device supply and treatment management. The U.S. alone was worth USD 4,988.2 Mn in 2025. Europe follows at 22.0% and Asia Pacific at 20.0%, with Asia Pacific the fastest-growing region after telemedicine reforms in South Korea and Japan, according to Vectomat Insights.
Which component is growing fastest?
Services are the fastest-growing component at a 20.86% CAGR, rising from USD 3,246.4 Mn in 2025 to USD 21,581.6 Mn in 2035, when they overtake devices as the largest component. That makes services the main source of new revenue in the market. Health systems are contracting nurse-led monitoring teams from companies such as Cadence instead of hiring staff to review readings themselves, according to Vectomat Insights.
What is driving demand for remote patient monitoring services?
Four forces drive demand: a chronic disease base that includes about 1.3 billion adults with hypertension, expanding reimbursement such as Medicare's CY2026 codes for 2–15 days of data, outsourcing of clinical monitoring to service providers, and longer-wear connected sensors like Dexcom's 15-day G7. Each of these lowers the cost of keeping a patient enrolled. Medicare RPM payments alone reached USD 536 Mn in 2024, according to Vectomat Insights.
Who are the leading companies in the remote patient monitoring services market?
Leading companies include Koninklijke Philips, Medtronic, Abbott Laboratories, Omron Healthcare, Dexcom, iRhythm Technologies, Masimo, Vivalink, Smart Meter, Teladoc Health, Biofourmis, Cadence, Health Recovery Solutions, CoachCare and ChartSpan. Together they cover sensors, platforms and managed clinical programs. Device makers control the sensor layer, while service providers are consolidating through deals such as ChartSpan's June 2026 purchase of Validic, according to Vectomat Insights.
What are the main risks for remote patient monitoring programs?
The biggest risk is compliance: HHS-OIG found that 43% of Medicare patients who received RPM in 2022 did not get all three required service components, and a 2025 follow-up report said some RPM billing poses a risk to Medicare. Each one adds cost per enrolled patient. Patient adherence, clinical staffing and home-device cybersecurity are the other main constraints that program operators must manage, according to Vectomat Insights.
Access the Complete Remote Patient Monitoring Services Market Report
300+ pages | Global coverage | PDF | 2026
Contact: sales@vectomatinsights.com
About Vectomat Insights
Vectomat Insights is an independent market research firm. Our analysts build every market model in-house, from company revenues, government and regulatory data, and interviews with industry participants, and each report is reviewed by a senior analyst and fact-checked before publication.
Contact: Vectomat Insights | Email: sales@vectomatinsights.com | Website: www.vectomatinsights.com · +1 416-876-0312